Literature DB >> 12211223

Coriolus versicolor: a medicinal mushroom with promising immunotherapeutic values.

Kevin K W Chu1, Susan S S Ho, Albert H L Chow.   

Abstract

Coriolus versicolor (CV) is a medicinal mushroom widely prescribed for the prophylaxis and treatment of cancer and infection in China. In recent years, it has been extensively demonstrated both preclinically and clinically that aqueous extracts obtained from CV display a wide array of biological activities, including stimulatory effects on different immune cells and inhibition of cancer growth. The growing popularity of aqueous CV extracts as an adjunct medical modality to conventional cancer therapies has generated substantial commercial interest in developing these extracts into consistent and efficacious oral proprietary products. While very limited information is available on the physical, chemical, and pharmacodynamic properties of the active principles present in these extracts, there has been sufficient scientific evidence to support the feasibility of developing at least some of these constituents into an evidence-based immunodulatory agent. In this article, the background, traditional usage, pharmacological activities, clinical effects, adverse reactions, active constituents, and regulatory aspects of CV are reviewed. Presented also in this review are the current uses and administration, potential drug interactions, and contraindication of aqueous extracts prepared from CV.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12211223

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  24 in total

1.  The known immunologically active components of Astragalus account for only a small proportion of the immunological adjuvant activity when combined with conjugate vaccines.

Authors:  Feng Hong; Weilie Xiao; Govind Ragupathi; Clara B S Lau; Ping Chung Leung; K Simon Yeung; Constantine George; Barrie Cassileth; Edward Kennelly; Philip O Livingston
Journal:  Planta Med       Date:  2010-12-02       Impact factor: 3.352

2.  Evaluation of widely consumed botanicals as immunological adjuvants.

Authors:  Govind Ragupathi; K Simon Yeung; Ping-Chung Leung; Mavis Lee; Clara Bik San Lau; Andrew Vickers; Chandra Hood; Gary Deng; Nai-Kong Cheung; Barrie Cassileth; Philip Livingston
Journal:  Vaccine       Date:  2008-07-18       Impact factor: 3.641

3.  Ethnomycological Investigation in Serbia: Astonishing Realm of Mycomedicines and Mycofood.

Authors:  Jelena Živković; Marija Ivanov; Dejan Stojković; Jasmina Glamočlija
Journal:  J Fungi (Basel)       Date:  2021-04-29

4.  Characterisation and bioactivity of protein-bound polysaccharides from submerged-culture fermentation of Coriolus versicolor Wr-74 and ATCC-20545 strains.

Authors:  Jian Cui; Kelvin Kim Tha Goh; Richard Archer; Harjinder Singh
Journal:  J Ind Microbiol Biotechnol       Date:  2007-02-22       Impact factor: 4.258

Review 5.  The effects of dietary supplementation with Agaricales mushrooms and other medicinal fungi on breast cancer: evidence-based medicine.

Authors:  Maria Rita Carvalho Garbi Novaes; Fabiana Valadares; Mariana Campos Reis; Daniella Rodrigues Gonçalves; Marilia da Cunha Menezes
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

6.  Phase 1 Clinical Trial of Trametes versicolor in Women with Breast Cancer.

Authors:  Carolyn J Torkelson; Erin Sweet; Mark R Martzen; Masa Sasagawa; Cynthia A Wenner; Juliette Gay; Amy Putiri; Leanna J Standish
Journal:  ISRN Oncol       Date:  2012-05-30

7.  Induction of cell cycle changes and modulation of apoptogenic/anti-apoptotic and extracellular signaling regulatory protein expression by water extracts of I'm-Yunity (PSP).

Authors:  Tze-chen Hsieh; Peili Wu; Spencer Park; Joseph M Wu
Journal:  BMC Complement Altern Med       Date:  2006-09-11       Impact factor: 3.659

8.  The Synergistic Beneficial Effects of Ginkgo Flavonoid and Coriolus versicolor Polysaccharide for Memory Improvements in a Mouse Model of Dementia.

Authors:  Xianying Fang; Yan Jiang; Hui Ji; Linguo Zhao; Wei Xiao; Zhenzhong Wang; Gang Ding
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-02       Impact factor: 2.629

9.  Single agent polysaccharopeptide delays metastases and improves survival in naturally occurring hemangiosarcoma.

Authors:  Dorothy Cimino Brown; Jennifer Reetz
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-05       Impact factor: 2.629

10.  Recent developments in mushrooms as anti-cancer therapeutics: a review.

Authors:  Seema Patel; Arun Goyal
Journal:  3 Biotech       Date:  2011-11-25       Impact factor: 2.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.